Medicare Enrolled
Dr. Rahul Bose, MD
Cardiovascular Disease · New Braunfels, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Bose from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bose? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bose
Dr. Rahul Bose is a cardiovascular disease in New Braunfels, TX, with 18 years in practice. Based on federal Medicare data, Dr. Bose performed 2,900 Medicare services across 2,019 unique beneficiaries.
Between the years covered by Open Payments, Dr. Bose received a total of $12,889 from 48 pharmaceutical and/or device companies across 386 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bose is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice▲ Top 36% volume in TX$ $12,889 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,900
Medicare services
Top 36% in TX for cardiovascular disease
2,019
Unique beneficiaries
$113
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~161 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 767 | $72 | $375 |
| Regadenoson injection (Lexiscan) for heart stress test | 284 | $43 | $188 |
| Echocardiogram, transthoracic | 235 | $145 | $652 |
| Hospital follow-up visit, moderate complexity | 204 | $60 | $207 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 110 | $47 | $209 |
| Telephone medical discussion with physician, 11-20 minutes | 109 | $54 | $265 |
| New patient office visit (45-59 min) | 106 | $93 | $489 |
| Initial hospital admission, moderate complexity | 100 | $97 | $391 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 95 | $331 | $1,332 |
| Cardiac catheterization | 84 | $181 | $840 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 71 | $89 | $356 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 68 | $132 | $561 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 63 | $76 | $280 |
| Ultrasound of both sides of head and neck blood flow | 54 | $147 | $585 |
| Office visit, established patient (20-29 min) | 49 | $51 | $267 |
| Telephone medical discussion with physician, 5-10 minutes | 44 | $32 | $164 |
| Ultrasound of leg arteries or artery grafts | 42 | $182 | $728 |
| Coronary stent placement | 39 | $407 | $1,668 |
| Remote pacemaker/defibrillator monitoring, 90 days | 36 | $15 | $68 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 36 | $9 | $32 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 36 | $148 | $534 |
| Chemical destruction of first incompetent vein of arm or leg using imaging guidance | 27 | $1,245 | $5,128 |
| Injection of chemical agent into single incompetent vein of leg using ultrasound guidance | 26 | $998 | $4,405 |
| Ultrasound of heart with probe in esophagus, with report | 26 | $81 | $319 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 25 | $40 | $155 |
| Remote pacemaker monitoring, 90 days | 23 | $21 | $89 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 22 | $46 | $222 |
| Programming of dual lead pacemaker system | 21 | $47 | $231 |
| Telephone medical discussion with physician, 21-30 minutes | 17 | $88 | $376 |
| Blood test, basic group of blood chemicals (calcium, ionized) | 15 | $13 | $41 |
| External shock to heart to regulate heart beat | 15 | $82 | $317 |
| Review by radiologist of both arms or legs arteries image | 14 | $130 | $504 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 13 | $181 | $952 |
| Review by radiologist of abdominal aorta image | 12 | $88 | $388 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 12 | $127 | $554 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
16.0% high complexity
27.7% medium
56.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$12,889
Total received (2018-2024)
Avg $1,841/year across 7 years
Top 27% in TX for cardiovascular disease
48
Companies
386
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,889 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$2,210
2023$1,933
2022$2,376
2021$1,167
2020$401
2019$1,717
2018$3,086
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$2,511
Abbott Laboratories
$1,601
BOSTON SCIENTIFIC CORPORATION
$1,571
Medtronic, Inc.
$1,029
Biosense Webster, Inc.
$714
Janssen Pharmaceuticals, Inc
$628
ABIOMED
$527
Novartis Pharmaceuticals Corporation
$412
BIOTRONIK INC.
$339
Medtronic Vascular, Inc.
$287
Amgen Inc.
$254
Merck Sharp & Dohme LLC
$244
Novo Nordisk Inc
$225
E.R. Squibb & Sons, L.L.C.
$207
Acist Medical Systems, Inc.
$190
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$187
Siemens Medical Solutions USA, Inc.
$181
Philips North America LLC
$178
AstraZeneca Pharmaceuticals LP
$151
ARALEZ PHARMACEUTICALS US INC.
$139
Edwards Lifesciences Corporation
$112
Philips Electronics North America Corporation
$110
CARDIVA MEDICAL, INC.
$109
Arrow International, Inc.
$98
Cardiovascular Systems Inc.
$84
Inari Medical, Inc.
$83
PFIZER INC.
$82
Impulse Dynamics (USA) Inc.
$70
Amarin Pharma Inc.
$63
Relypsa, Inc.
$56
Kiniksa Pharmaceuticals International, plc
$41
Esperion Therapeutics, Inc.
$40
Merck Sharp & Dohme Corporation
$39
CVRx, Inc.
$39
Surmodics, Inc.
$31
Tactile Systems Technology Inc
$31
Baxter Healthcare
$29
Chiesi USA, Inc.
$26
Shockwave Medical, Inc
$24
Actelion Pharmaceuticals US, Inc.
$24
Cook Medical LLC
$23
bsn medical inc
$22
GE HealthCare
$18
SCPHARMACEUTICALS INC.
$18
Bard Peripheral Vascular, Inc.
$17
Davol Inc.
$15
Thrombolex, Inc.
$6
CashFlow Solutions, LLC
$6
Top 3 companies account for 44.1% of total payments
Associated products mentioned in payments ›
(4067) Tack Endo Sys BTK · (5027) Intact Vascular Und · (5153) Azurion 5 M20 GC · (8334) IGT D Peripheral · (9281) Turbo Elite · (P84) IGT Devices Systems · ABSOLUTE PRO · ACTIMOVE · AMPLATZER Occluders · ARISTA AH FLEXITIP · AVEIR · Acticor · Arcalyst · Artis Q ceiling · Artis Q floor · Artis pheno · Assurity Pacemaker · BRILINTA · Barostim Neo System · Bashir Endovascular Catheter · BioMonitor · CARDIOMEMS · CARDIVA VASCADE MVP VVCS 6-12F · CARTO 3 · CONFIRM RX · COOK MEDICAL SELF-EXPANDING STENT · COREVALVE EVOLUT R · CVI Systems · CardioMEMS HF System · CareLink · Carto 3 System · Carto Smarttouch · Catheter - GuideLiner · CoreValve Evolut · DIAMONDBACK CORONARY · DRAGONFLY OPSTAR · Denali Vena Cava Filter · Diamondback Coronary · Diamondback Peripheral · Dragonfly OCT · EKOSONIC · ELIQUIS · ELUVIA · ENSOETM · ENTRESTO · EkoSonic · FLOWTRIEVER CATHETER · FUROSCIX · Flexitouch Plus · GENERAL THERAPIES · GENERAL ANGIOGRAPHY · GENERAL TACHY · GENERAL THERAPIES · GENERAL - THERAPIES · GENERAL - VASCULAR ACCESS · GENERAL ATHERECTOMY · GENERAL METALLIC STENTS · GENERAL TACHY · GENERAL THERAPIES · GENERAL ULTRASOUND · GENERAL VASCULAR ACCESS · General - Atherectomy · General - Therapies · General - Ultrasound · General - Vascular Intervention · HeartMate 3 Left Ventricular Assist Device · Hillrom - Carnation Ambulatory Monitor · Impella · JOURNEY · KENGREAL · KYPHON EXPRESS II KYPHOPAK TRAY · LATITUDE · LATITUDE Communicator Power Supply · LEQVIO · LUX-Dx Insertable Cardiac Monitor · LYMPHA PRESS OPTIMAL PLUS(US) BT · LifeVest · MITRACLIP · MULTI-LINK MINI VISION · Micra · NA · NEXLETOL · NITINOL · No Associated Product · OPSUMIT MACITENTAN · OPTIMIZER · OPTIS · Optimizer · Ozempic · PERCLOSE PROGLIDE · PRESSUREWIRE · Peripheral RotaLink Plus · PressureWire FFR · RESOLUTE ONYX · ROTAPRO · RXi Systems · Repatha · Reveal LINQ · Rybelsus · S · SAPIEN 3 Ultra RESILIA · SAVVYWIRE · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · SYNERGY · Sublime 014 Rx PTA Balloon Dilatation Catheter · Supera peripheral stent system · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · TURBOHAWK · Turbo Elite · Unify Assura CRT Defibrillator · VENASEAL · VERQUVO · Vascepa · Veltassa · VenaSeal · WALLSTENT · WATCHMAN · WATCHMAN Access System · XARELTO · XIENCE SIERRA · XIENCE SKYPOINT · Xience Sierra CSS · Xience Sierra Coronary Stent · ZONTIVITY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $444 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
34
Per 100K population
19.1
County median income
$93,776
Nearest hospital
RESOLUTE HEALTH HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Bose is a clinical cardiology specialist, with moderate Medicare volume, and low-engagement industry engagement, with 18 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Bose experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Bose performed 767 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bose receive payments from pharmaceutical companies?
Yes. Dr. Bose received a total of $12,889 from 48 companies across 386 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bose's costs compare to other cardiovascular diseases in New Braunfels?
Dr. Bose's average Medicare payment per service is $113. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bose) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in New Braunfels
Browse cardiovascular diseases in New Braunfels ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in TX
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in TX
Which TX cardiovascular diseases receive the most from drug and device companies.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
BOSTON SCIENTIFIC CORPORATION Payments to Doctors
See all physicians who received payments from BOSTON SCIENTIFIC CORPORATION.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology